Part I of this series explained China’s general rules on foreign-related jurisdiction. In Part II, Jianwei(Jerry) Fang, Ke Dong and Haoyi Sun of Zhong LunLaw Firm show how Chinese courts will, in ...

Anonymization of personal information needs to satisfy de-identification and irreversibility. Criteria are set forth for cross-border delivery services provided by foreign financial infrastructure ...

Proposed AI Ethics rules will require ethical committees in institutions; Japanese brand Muji’s two-decades old trademark dispute ends in defeat; and China steps up Belt and Road investment as Western ...

China Law News legal coverage, commentary, and expert analysis from Law.com.

-The continuing trend is for a widening of the scope of data which will not require onerous ex ante/ex post procedures “There are typically no specific restrictions on the export of general business ...

Jun Luo, Director of the Legal and Compliance Department at Shanghai SSCI Leading Fund Co., Ltd, and Taolue Zhang, Vice-Professor and Director of Tongji Intellectual Property and Competition Law ...

In 2024, the United States continued to impose new investment and technology restrictionson Chinese interests The difference between that year and preceding years’ restrictions was the impact those ...

2024 marked the establishment of a comprehensive framework for cross-border data transfers, and the issuing of regulations on the administration of network data security In addition to national ...

The reciprocal Hong Kong-mainland China interim measures arrangement allows parties in certain arbitral proceedings to apply directly to each other's respective courts to seek interim measures before ...

Simon Leung, Partner of Baker McKenzie, and Terry Xu, Senior Counsel at FenXun Partners, examine key regulatory shifts in 2024 and provide an outlook of potential regulatory trends for the banking and ...

As the sector makes the transition from creative limitation to genuine innovation Harmonization was another key theme, in order to facilitate both "coming in" and "going out" 2024 was a year which saw ...

U.S. President Donald Trump’s recent executive order on drug pricing is built around a Most Favored Nation pricing policy China’s pharmaceutical industry has evolved from primarily a license-in ...